{{Rsnum
|rsid=1514348
|Gene=ESR1
|Chromosome=6
|position=151861180
|Orientation=minus
|GMAF=0.4697
|Gene_s=ESR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 33.6 | 53.1 | 13.3
| HCB | 29.9 | 45.3 | 24.8
| JPT | 25.7 | 48.7 | 25.7
| YRI | 7.5 | 52.4 | 40.1
| ASW | 15.8 | 45.6 | 38.6
| CHB | 29.9 | 45.3 | 24.8
| CHD | 25.7 | 50.5 | 23.9
| GIH | 31.7 | 55.4 | 12.9
| LWK | 6.4 | 50.9 | 42.7
| MEX | 48.3 | 44.8 | 6.9
| MKK | 20.5 | 46.8 | 32.7
| TSI | 45.1 | 35.3 | 19.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23641305
|Title=ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population
|OA=1
}}

{{PMID Auto
|PMID=18305958
|Title=Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}